Home/Bio-Rad/Andrew J. Last
AJ

Andrew J. Last

Chief Executive Officer

Bio-Rad

Bio-Rad Pipeline

DrugIndicationPhase
Next-Gen ddPCR Oncology AssaysNSCLC Mutation Detection (Liquid Biopsy)Commercial
ddPCR Technology EvolutionBroad Life Science & Clinical ApplicationsR&D
Process Chromatography SolutionsBiopharmaceutical PurificationCommercial Expansion
Clinical Diagnostics Assay MenuVarious (Autoimmune, Virology, etc.)Regulatory/Commercial